Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Canada
  4. CANADIAN NATIONAL STOCK EXCHANGE
  5. Medcolcanna Organics Inc.
  6. Company
    MCCN   CA58406X1050

MEDCOLCANNA ORGANICS INC.

(MCCN)
Delayed CANADIAN NATIONAL STOCK EXCHANGE  -  10:05:59 2022-07-06 am EDT
0.005000 CAD   -66.67%
2022Medcolcanna Organics Inc. Announces Execution of Two Definitive Colombian Supply Agreements and Two Eu Sales Agreements for EUGMP and Cums-Imc Certified Dried Flower
CI
2022IIROC Trading Halt - MCCN
AQ
2022Medcolcanna Organics Inc. Announces Resignation of Pablo Abba Vieira as A Member of the Board of Director
CI
SummaryQuotesChartsNewsCalendarCompanyFinancialsFunds 
Business Summary
Medcolcanna Organics Inc. (Medcolcanna) is a Canada-based integrated medicinal cannabis company with operations in Colombia. The Company is engaged in cultivation and conversion of cannabis into raw materials, commodities, and finished cannabis products for the global market, such as nutraceuticals, cosmetics, and medicinal products. Its products and services portfolio include commodities, white label services and other services. Its other services include in vitro plants, cuttings, fresh and dry flower, biomass, third party crop operation and technical assistance. The Company, through its subsidiaries, is engaged in providing extraction services and involved in the cannabis distribution and vaping industry. The Company, through its wholly owned subsidiary, Medcolcanna S.A.S, is engaged in sowing and cultivation of psychoactive and non-psychoactive cannabis plants, and manufacturing of cannabis derivatives in Colombia. Its other subsidiaries include Extralia Labs SAS and MCCN SA.

Number of employees : 1 800 people.
Sales per Business
20192020Delta
Vape Products0.00100%0.10100% +5953.98%
CAD in Million
Sales per region
20192020Delta
Switzerland0.00100%0.0665.3% +3851.26%
Colombia--0.0334.7%-
CAD in Million
Managers
Name Title Age Since
Felipe de la Vega Vargara President, Chief Executive Officer & Director 42 2019
Christopher Donald Reid Chief Financial Officer & Director 44 -
Ana María Borda, Dr. Director-Research & Development - 2019
Nicolas Rodriguez Chief Operating Officer 40 2019
Yenny Ariza Administrative Manager - -
Juan José Arango Director-Marketing & Design - 2019
Harm Hids Head-Product Development & Business Development - -
Members of the board
Name Title Age Since
Robert James Metcalfe Chairman 82 2019
Christopher Donald Reid Chief Financial Officer & Director 44 -
Felipe de la Vega Vargara President, Chief Executive Officer & Director 42 2019
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 116,406,789 33,282,726 28.6% 0 0.0% 28.6%
Shareholders
NameEquities%
Thomas Yang 50,000,000 29.8%
Morsevo Trade, Inc. 14,876,900 8.86%
Felipe de la Vega Vargara 11,241,827 6.69%
Christopher Donald Reid 6,160,277 3.67%
Daniel Herrera 836,176 0.50%
Robert James Metcalfe 825,059 0.49%
Thor Borresen 542,691 0.32%
José Joaquín Mora 155,061 0.092%
Pablo Vieira 155,061 0.092%
Company contact information
Medcolcanna Organics, Inc.
Carrera 49b, No. 93-62
Bogota, Cundinamarca 253001

Web : http://www.medcolcanna.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Medcolcanna Organics Inc.
Sector Pharmaceuticals
1st jan.Capi. (M$)
MEDCOLCANNA ORGANICS INC.-90.00%1
JOHNSON & JOHNSON-4.77%439 835
ELI LILLY AND COMPANY-4.87%325 056
NOVO NORDISK A/S1.06%312 363
ROCHE HOLDING AG-0.40%277 685
MERCK & CO., INC.-5.02%267 180
ABBVIE INC.-9.49%258 606
PFIZER, INC.-13.64%245 807
ASTRAZENECA PLC-5.31%203 823
NOVARTIS AG-1.21%192 852
BRISTOL-MYERS SQUIBB COMPANY1.45%160 813
AMGEN INC.-3.42%135 342
SANOFI-0.32%121 261
GILEAD SCIENCES, INC.-2.47%105 018
CSL LIMITED2.41%101 009
MERCK KGAA5.25%89 863
ZOETIS12.71%76 986
GSK PLC-1.92%70 897
DAIICHI SANKYO CO., LTD.2.00%63 966
BAYER AG16.46%60 020
MCKESSON CORPORATION2.40%53 768